$VBIO
Valion Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.53
▲+6.30%+$0.150
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateValion Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is VBIO up today? It is at $2.53 (+6.30%), and our scanner flagged it 58 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VBIO spikes, and full due diligence on VBIO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VBIO 58 times in the last 30 days. Create a free account to track $VBIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
VBIO is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on VBIO today.
Likely catalystValion Bio Announces Changes to ManagementReported Entolimod targets the projected $7.8 billion Acute Radiation Syndrome ("ARS") market by 2032 and a multi-billion-dollar oncologyReverse split up to 1-for-25Status pending stockholder approval, from an SEC filing. Read it →Latest filing3Initial insider ownership (Form 3)Sep 17, 2026 · 5 days agoAcross every filing on file, supply equal to 750.5% of the tradeable float is in play - 6.5% has already been sold, and 744% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent share offering + active shelf on file — the company raised capital and can raise more
55,729 new shares (adjusted for the later reverse split) · About $50.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
VBIO is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on VBIO today.
VBIO last traded at $2.53, up 6.30% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Valion Bio, Inc. Common Stock (VBIO) is next expected to report earnings on Friday, November 13, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VBIO 58 times in the last 30 days.
VBIO (Valion Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $2M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VBIO discussion
Sign in to ask a question or join the discussion.